KUALA LUMPUR, Sept 21 -- Anaqua, the leading innovation and intellectual property management technology provider, has announced that global medical products and technologies group ConvaTec will use Anaqua’s AQX platform to help more effectively manage their valuable patent and trademark portfolios.
According to a statement, the agreement further strengthens Anaqua’s position in the medical solutions markets, with a growing number of clients from these sectors collaborating with Anaqua as their preferred IP management provider.
“For our part, we look forward to helping ConvaTec protect their innovation and IP management needs. We are also delighted to add another global company to our growing portfolio of clients in the healthcare and life sciences sectors,” said Anaqua Chief Executive Officer, Bob Romeo.
With operations in over 100 countries, ConvaTec is a global medical and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence care, critical care, and infusion care.
ConvaTec products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.
ConvaTec will use Anaqua’s AQX platform for patent and trademark management, annuities and renewals (in conjunction with Anaqua Services), and patent analytics through integration with Anaqua’s AcclaimIP.
Anaqua’s AQX platform combines best practice workflows with big data analytics and tech-enabled services to create an intelligent environment designed to inform IP strategy, enable IP decision-making, and streamline IP operations.
-- BERNAMA
No comments:
Post a Comment